Arterial Plaque (Atherosclerosis)

LDL particles carrying apolipoprotein B penetrate the artery wall, become trapped, and oxidize, triggering the inflammatory cascade that forms plaque. Cumulative lifetime exposure to apoB is the main causal driver of atherosclerosis. Genetic conditions like familial hypercholesterolemia dramatically accelerate this process.

Once LDL is trapped, immune cells migrate in, engulf it, and become foam cells that build the fatty streak. Conditions such as rheumatoid arthritis, lupus, chronic gum disease, and persistent infections raise background inflammation and speed plaque growth. Inflammation also destabilizes existing plaque, making rupture more likely.

High blood pressure physically damages the endothelial lining, especially at artery branch points, creating entry sites for LDL. It also thickens and stiffens the arterial wall over time. This is why plaque clusters where blood flow is turbulent.

High insulin and glucose levels glycate proteins, raise small dense LDL and triglycerides, lower HDL, and impair nitric oxide production. This combination is one of the fastest routes to diffuse plaque. Diabetes is considered a coronary risk equivalent for this reason.

Tobacco smoke directly poisons the endothelium, promotes clotting, oxidizes LDL, and lowers HDL. Fine particulate pollution works through similar oxidative and inflammatory pathways. Risk begins to fall within months of quitting.

Statins such as atorvastatin or rosuvastatin lower LDL production in the liver and have independent plaque-stabilizing and anti-inflammatory effects, directly targeting the apoB and inflammation causes. High-intensity statins can halt progression and modestly regress plaque volume on imaging. Muscle aches occur in a minority and often resolve with a dose change or alternate agent.

Ezetimibe blocks intestinal cholesterol absorption and PCSK9 inhibitors (injectables like evolocumab, or inclisiran) sharply increase LDL receptor clearance, addressing elevated LDL/apoB when statins alone are insufficient or not tolerated. Combination therapy can drive LDL below 55 mg/dL in high-risk patients. These are typically added after statin maximization.

ACE inhibitors, ARBs, calcium channel blockers, or thiazides reduce the mechanical shear stress and endothelial injury that let LDL enter the artery wall. Targeting roughly 120-130 mmHg systolic substantially lowers stroke and heart attack risk. Home monitoring helps verify true control.

Low-dose aspirin (for those with established disease) reduces clot formation on ruptured plaque, while metformin, SGLT2 inhibitors, and GLP-1 agonists treat the insulin resistance and diabetes driving plaque. Several of these agents have proven cardiovascular outcome benefits beyond glucose lowering. Aspirin for primary prevention is individualized because of bleeding risk.

A coronary artery calcium (CAC) score or CT angiography quantifies existing plaque burden and guides how aggressively to treat, while carotid ultrasound screens neck arteries. When flow-limiting lesions cause symptoms, angioplasty with stenting or bypass surgery restores perfusion. Imaging does not replace risk-factor treatment but personalizes its intensity.

Thirty to forty-five minutes of brisk walking, cycling, or swimming most days raises HDL function, improves insulin sensitivity, lowers blood pressure, and boosts endothelial nitric oxide. It directly counters the insulin resistance and hypertension causes. Adding two resistance sessions weekly improves body composition further.

Emphasizing olive oil, vegetables, legumes, nuts, fish, and whole grains lowers LDL, triglycerides, and inflammatory markers in randomized trials such as PREDIMED. It addresses both the lipid and inflammation drivers of plaque. It is the most evidence-backed dietary approach for cardiovascular prevention.

Stopping tobacco and nicotine removes a direct endothelial toxin, and risk drops measurably within the first year. Using a HEPA filter and avoiding exercise near heavy traffic reduces particulate exposure. This targets the oxidative-injury cause of plaque.

Daily paced breathing, meditation, or a 20-minute walk lowers cortisol and sympathetic tone that raise blood pressure and inflammation. Treating snoring and sleep apnea is especially important because untreated apnea drives nocturnal hypertension and arterial stress. Aim for seven to nine hours of consistent sleep.

Twice-daily brushing, daily flossing, and professional cleanings reduce the chronic bacterial inflammation from periodontitis that is epidemiologically linked to atherosclerosis. Lowering this inflammatory load may slow plaque progression. It is a cheap, low-risk adjunct to standard care.

Rich in EPA and DHA omega-3 fats that lower triglycerides, reduce arterial inflammation, and make platelets less sticky. Two to three servings weekly is associated with lower cardiac death rates. Sardines and salmon also supply vitamin D and selenium.

Supplies monounsaturated fat plus polyphenols like oleocanthal and hydroxytyrosol that reduce LDL oxidation and improve endothelial function. In the PREDIMED trial, high olive oil intake cut major cardiovascular events by roughly 30 percent. Use it raw over salads and vegetables to preserve the polyphenols.

Their soluble beta-glucan and viscous fiber binds bile acids in the gut, forcing the liver to pull LDL cholesterol from the blood. Three grams of beta-glucan daily lowers LDL by about 5-10 percent. Legumes additionally blunt post-meal glucose spikes that worsen insulin resistance.

Provide plant sterols, arginine, magnesium, and unsaturated fats that lower LDL and improve blood vessel relaxation. A handful (about 30 g) daily is linked to reduced coronary events in cohort studies. Choose unsalted versions to avoid added sodium.

High in dietary nitrate, which the body converts to nitric oxide to dilate arteries and lower blood pressure. They also deliver folate, potassium, magnesium, and vitamin K1, which is associated with less arterial calcification. Aim for a cup or more daily.

Anthocyanins and punicalagins are potent antioxidants that reduce LDL oxidation and improve endothelial flow-mediated dilation in small trials. Regular berry intake is associated with lower myocardial infarction risk in long-term cohorts. Whole fruit is preferable to juice because of fiber and lower sugar load.

Allicin and related organosulfur compounds modestly lower blood pressure and LDL and reduce platelet aggregation. Effects are small but consistent across meta-analyses. Crushing garlic and letting it stand 10 minutes before cooking preserves more active compounds.

They simultaneously raise LDL and lower HDL while promoting systemic inflammation and endothelial dysfunction. Even small intakes are linked to disproportionate coronary risk. Check labels on baked goods, frostings, and some fried foods even when the package claims zero grams.

Bacon, sausage, salami, and hot dogs combine high sodium, saturated fat, nitrites, and heme iron, a mix associated with higher coronary and stroke risk. The sodium raises blood pressure while nitrosamines impair endothelial function. Risk rises measurably with each additional daily serving.

Liquid fructose and sucrose drive hepatic de novo lipogenesis, raising triglycerides and small dense LDL while worsening insulin resistance. They provide calories without satiety, promoting visceral fat gain. One or more servings daily is associated with meaningfully higher cardiovascular risk.

White bread, pastries, and sweetened cereals cause rapid glucose and insulin spikes that promote glycation and arterial inflammation. They displace the soluble fiber that would otherwise lower LDL. High-glycemic diets correlate with increased coronary events, especially in insulin-resistant people.

Repeatedly heated oils generate oxidized lipids and aldehydes that directly injure the arterial lining and accelerate LDL oxidation. These foods are also energy dense and high in sodium. Frequent fried-food intake is independently associated with coronary disease.

Excess sodium raises blood pressure, which increases shear stress on the endothelium and accelerates plaque formation. Most dietary sodium comes from processed foods rather than the salt shaker. Keeping intake near 1,500-2,300 mg daily meaningfully lowers pressure in salt-sensitive individuals.

More than one to two drinks daily raises blood pressure and triglycerides, promotes atrial fibrillation, and adds empty calories driving visceral fat. The supposed cardioprotective effect of moderate drinking has weakened considerably in genetic and modern cohort analyses. Those with high triglycerides or hypertension should minimize or avoid it.

Lowers triglycerides and arterial inflammation; prescription icosapent ethyl at 4 g/day reduced cardiovascular events in the REDUCE-IT trial (strong evidence in that specific high-triglyceride population), while general fish oil supplements show weaker outcome benefit. Typical over-the-counter dosing is 1-2 g combined EPA/DHA daily. High doses modestly increase atrial fibrillation and bleeding risk, so discuss with your doctor if you take anticoagulants.

Activates matrix Gla protein, which inhibits calcium deposition in arterial walls; observational data and some trials suggest less arterial stiffening, but outcome evidence is still limited and not conclusive for regressing plaque. Typical dose is 90-180 mcg daily, often paired with vitamin D. It is contraindicated with warfarin because it directly opposes the drug's mechanism.

Binds bile acids to reduce LDL cholesterol by roughly 5-10 percent, with good evidence from multiple randomized trials. Typical dose is 5-10 g daily taken with ample water, started low to avoid bloating. Take it separated by at least two hours from other medications, which it can bind.

Compete with cholesterol for intestinal absorption and lower LDL by about 8-10 percent at 2 g daily, an effect recognized by major cardiology guidelines. Found in fortified spreads or as capsules. People with the rare genetic disorder sitosterolemia must avoid them.

Contains monacolin K, which is chemically identical to lovastatin, so it genuinely lowers LDL but carries the same muscle and liver risks as a statin. Product potency varies widely and some batches contain the toxin citrinin, making quality a real concern. Never combine with a prescription statin, and avoid in pregnancy or liver disease.

May reduce statin-associated muscle symptoms in some people and has modest supportive data in heart failure, though evidence for plaque reduction itself is weak. Typical dose is 100-200 mg daily of ubiquinol or ubiquinone with a fatty meal. It can slightly reduce warfarin's effect, so monitoring is needed.

Supports blood pressure regulation, endothelial function, and insulin sensitivity, with meta-analyses showing small but real blood pressure reductions. Typical dose is 200-400 mg daily of glycinate or citrate; oxide is poorly absorbed and more laxative. Those with chronic kidney disease should not supplement without physician supervision because of accumulation risk.